We quantified plasma NfL levels in two unique pediatric patient populations: healthy children with HTT expansion mutations expected to produce adult‐onset disease (premanifest Huntington's disease [preHD]) and those with JOHD. Here, NEFL is linked to juvenile Huntington disease.